遗传性血管性水肿女性患者的管理
Managing the female patient with hereditary angioedema.
作者信息
Banerji Aleena, Riedl Marc
机构信息
Massachusetts General Hospital, Cox 201, 55 Fruit Street, Boston, MA, USA.
University of California, San Diego, La Jolla, CA, USA.
出版信息
Womens Health (Lond). 2016 Jun;12(3):351-61. doi: 10.2217/whe.16.6. Epub 2016 Mar 15.
Abstract
Hereditary angioedema (HAE) is a rare disorder resulting from decreased functional levels of C1-inhibitor (C1-INH), which manifests as periodic episodes of localized edema which can be extremely painful, debilitating and even fatal if the swelling affects the larynx. HAE can complicate many aspects of obstetric/gynecologic care, and an awareness of the disease is critical for clinicians involved in the care of women because of potential HAE-related complications pertaining to pregnancy, labor and delivery, and other women's health issues. This article provides a review of published literature specific to HAE and its management in female patients, including important concerns regarding obstetric/gynecologic care. A growing body of relevant experience is presented to help guide the care of women with HAE.
摘要
遗传性血管性水肿（HAE）是一种罕见的疾病，由C1抑制剂（C1-INH）功能水平降低引起，表现为局部水肿的周期性发作，如果肿胀影响喉部，可能会极其疼痛、使人衰弱甚至致命。HAE会使产科/妇科护理的许多方面变得复杂，对于参与女性护理的临床医生来说，了解这种疾病至关重要，因为与HAE相关的潜在并发症涉及妊娠、分娩和其他女性健康问题。本文综述了关于HAE及其在女性患者中的管理的已发表文献，包括与产科/妇科护理相关的重要问题。本文还介绍了越来越多的相关经验，以帮助指导HAE女性患者的护理。
相似文献
1
Managing the female patient with hereditary angioedema.遗传性血管性水肿女性患者的管理
Womens Health (Lond). 2016 Jun;12(3):351-61. doi: 10.2217/whe.16.6. Epub 2016 Mar 15.
2
Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.C1抑制剂缺乏所致遗传性血管性水肿的当前治疗选择。
Expert Opin Pharmacother. 2016;17(1):27-40. doi: 10.1517/14656566.2016.1104300. Epub 2015 Oct 29.
3
Recent advances in the management of hereditary angioedema.遗传性血管性水肿治疗的最新进展
J Am Osteopath Assoc. 2013 Jul;113(7):546-55. doi: 10.7556/jaoa.2013.006.
4
Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: the Italian experience.C1 抑制剂缺乏所致遗传性血管性水肿的诊断与治疗管理：意大利的经验
Curr Opin Allergy Clin Immunol. 2015 Aug;15(4):383-91. doi: 10.1097/ACI.0000000000000186.
5
New treatment options for acute edema attacks caused by hereditary angioedema.遗传性血管性水肿急性发作所致急性水肿的新治疗选择。
Am J Health Syst Pharm. 2011 Nov 15;68(22):2129-38. doi: 10.2146/ajhp100718.
6
Clinical presentation, pathophysiology, diagnosis, and treatment of acquired and hereditary angioedema: Exploring state-of-the-art therapies in RI.
R I Med J (2013). 2016 Jun 1;99(6):41-4.
7
Current and emerging management options for hereditary angioedema in the US.美国遗传性血管性水肿的当前及新出现的管理方案
Drugs. 2008;68(18):2561-73. doi: 10.2165/0003495-200868180-00003.
8
A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).十年之变：遗传性血管性水肿（HAE）药物治疗的最新进展
Clin Rev Allergy Immunol. 2016 Oct;51(2):183-92. doi: 10.1007/s12016-016-8544-9.
9
Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency.遗传性血管性水肿患儿的管理。
Pediatrics. 2016 Nov;138(5). doi: 10.1542/peds.2016-0575.
10
Training hereditary angioedema patients to self-administer intravenous C1 esterase inhibitor concentrate.培训遗传性血管性水肿患者自行静脉注射C1酯酶抑制剂浓缩物。
J Infus Nurs. 2014 Jul-Aug;37(4):284-90. doi: 10.1097/NAN.0000000000000049.
引用本文的文献
1
Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous and Intravenous Garadacimab Following Single-Dose Administration in Healthy Japanese and White Adults.健康日本和白人成年人单剂量皮下及静脉注射加拉达昔单抗后的药代动力学、药效学及安全性
J Clin Pharmacol. 2025 Apr;65(4):466-477. doi: 10.1002/jcph.6162. Epub 2024 Nov 24.
2
Rare connective tissue diseases in patients with C1-inhibitor deficiency hereditary angioedema: first evidence on prevalence and distribution from a large Italian cohort study.C1 抑制剂缺乏性遗传性血管性水肿患者中的罕见结缔组织病：来自大型意大利队列研究的首个患病率和分布证据。
Front Immunol. 2024 Oct 18;15:1461407. doi: 10.3389/fimmu.2024.1461407. eCollection 2024.
3
A real-world study of hereditary angioedema patients due to C1 inhibitor deficiency treated with danazol in the Brazilian Public Health System.在巴西公共卫生系统中，对因C1抑制剂缺乏而接受达那唑治疗的遗传性血管性水肿患者进行的一项真实世界研究。
Front Med (Lausanne). 2024 Sep 6;11:1343547. doi: 10.3389/fmed.2024.1343547. eCollection 2024.
4
The complexities of decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacks.与遗传性血管性水肿（HAE）发作按需治疗相关的决策复杂性。
Allergy Asthma Clin Immunol. 2024 Jul 25;20(1):43. doi: 10.1186/s13223-024-00903-w.
5
Sex- and species-associated differences in complement-mediated immunity in humans and rhesus macaques.人类和恒河猴补体介导免疫中的性别和物种相关差异。
mBio. 2024 Mar 13;15(3):e0028224. doi: 10.1128/mbio.00282-24. Epub 2024 Feb 22.
6
Sex and species associated differences in Complement-mediated immunity in Humans and Rhesus macaques.人类和恒河猴中补体介导免疫的性别及物种相关差异
bioRxiv. 2023 Oct 25:2023.10.23.563614. doi: 10.1101/2023.10.23.563614.
7
Increased thromboinflammatory load in hereditary angioedema.遗传性血管性水肿患者血栓炎症负荷增加。
Clin Exp Immunol. 2023 Dec 12;214(2):170-181. doi: 10.1093/cei/uxad091.
8
Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema.遗传性血管性水肿生活质量问卷的内容验证和心理计量学评估
J Patient Rep Outcomes. 2023 Apr 3;7(1):33. doi: 10.1186/s41687-023-00576-w.
9
Pregnancy in women with Hereditary Angioedema due to C1-inhibitor deficiency: Results from the ITACA cohort study on outcome of mothers and children with exposure to plasma-derived C1-inhibitor.C1抑制剂缺乏所致遗传性血管性水肿女性的妊娠：ITACA队列研究中母亲和儿童暴露于血浆源性C1抑制剂的结局结果
Front Med (Lausanne). 2022 Sep 14;9:930403. doi: 10.3389/fmed.2022.930403. eCollection 2022.
10
A novel murine in vivo model for acute hereditary angioedema attacks.一种用于急性遗传性血管性水肿发作的新型小鼠体内模型。
Sci Rep. 2021 Aug 5;11(1):15924. doi: 10.1038/s41598-021-95125-0.
本文引用的文献
1
Bradykinin-activated contractile signalling pathways in human myometrial cells are differentially regulated by arrestin proteins.缓激肽激活的人子宫肌层细胞收缩信号通路受抑制蛋白的差异调节。
Mol Cell Endocrinol. 2015 May 15;407:57-66. doi: 10.1016/j.mce.2015.03.004. Epub 2015 Mar 9.
2
Current medical management of hereditary angioedema: follow-up survey of US physicians.遗传性血管性水肿的当前医学管理：美国医生的随访调查
J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):220-7. doi: 10.1016/j.jaip.2014.08.017. Epub 2014 Nov 18.
3
C1 inhibitor deficiency: 2014 United Kingdom consensus document.C1 抑制剂缺乏症：2014 年英国共识文件。
Clin Exp Immunol. 2015 Jun;180(3):475-83. doi: 10.1111/cei.12584. Epub 2015 May 13.
4
Caesarean delivery in a parturient with type III hereditary angioedema.III型遗传性血管性水肿产妇的剖宫产分娩
Int J Obstet Anesth. 2014 Nov;23(4):398-9. doi: 10.1016/j.ijoa.2014.05.010. Epub 2014 Jun 5.
5
Training hereditary angioedema patients to self-administer intravenous C1 esterase inhibitor concentrate.培训遗传性血管性水肿患者自行静脉注射C1酯酶抑制剂浓缩物。
J Infus Nurs. 2014 Jul-Aug;37(4):284-90. doi: 10.1097/NAN.0000000000000049.
6
US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency.美国遗传性血管性水肿协会医学顾问委员会 2013 年关于 C1 抑制剂缺乏所致遗传性血管性水肿管理的建议。
J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):458-67. doi: 10.1016/j.jaip.2013.07.002. Epub 2013 Aug 30.
7
Hereditary angioedema with normal C1-INH (HAE type III).遗传性血管性水肿伴正常 C1-INH（HAE 型 III）。
J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):427-32. doi: 10.1016/j.jaip.2013.06.004. Epub 2013 Aug 2.
8
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies.性激素与绝经前妇女乳腺癌风险：来自 7 项前瞻性研究的个体参与者数据的合作重新分析。
Lancet Oncol. 2013 Sep;14(10):1009-19. doi: 10.1016/S1470-2045(13)70301-2. Epub 2013 Jul 24.
9
A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema.重点参数更新：遗传性血管性水肿、获得性 C1 抑制剂缺乏症和血管紧张素转换酶抑制剂相关性血管性水肿。
J Allergy Clin Immunol. 2013 Jun;131(6):1491-3. doi: 10.1016/j.jaci.2013.03.034.
10
Benefits of progestin contraception in non-allergic angioedema.孕激素避孕在非过敏性血管性水肿中的益处。
Clin Exp Allergy. 2013 Apr;43(4):475-82. doi: 10.1111/cea.12055.
Zotero 插件